SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 78 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $132,000 | +36.1% | 136,939 | +66.3% | 0.00% | – |
| Q1 2022 | $97,000 | -95.0% | 82,354 | -76.8% | 0.00% | -100.0% |
| Q2 2021 | $1,932,000 | +1433.3% | 354,453 | +2942.0% | 0.01% | – |
| Q4 2020 | $126,000 | +207.3% | 11,652 | +148.7% | 0.00% | – |
| Q3 2020 | $41,000 | -93.1% | 4,686 | -91.6% | 0.00% | -100.0% |
| Q2 2020 | $598,000 | +228.6% | 56,026 | +112.2% | 0.00% | +200.0% |
| Q4 2019 | $182,000 | +83.8% | 26,405 | +144.8% | 0.00% | – |
| Q1 2019 | $99,000 | +50.0% | 10,788 | +95.0% | 0.00% | – |
| Q3 2018 | $66,000 | -77.1% | 5,531 | -80.4% | 0.00% | -100.0% |
| Q2 2018 | $288,000 | +5660.0% | 28,233 | +7084.0% | 0.00% | – |
| Q1 2018 | $5,000 | – | 393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |